Brainstorm Cell Therapeutics reported 0 in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Biogen USD 2.8B 60M Sep/2026
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cipla INR 74.04B 2.85B Sep/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 2.6M 3.75M Jun/2026
CSL USD 8.33B 4.79B Dec/2025
Cytokinetics USD 47.6M 19M Sep/2026
Gilead Sciences USD 8.3B 500M Sep/2026
Grifols EUR 2B 306.7M Mar/2026
Halozyme Therapeutics USD 492.97M 11.97M Sep/2026
Mesoblast USD 63.9M 33.6M Jun/2026